7561 - 7570 of 9036 Results
Title
Year
-
OPENTitle: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 43Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aaz9360Best OA location URL: https://advances.sciencemag.org/content/advances/6/43/eaaz9360.full.pdfCitation Count: 388
-
OPENTitle: Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 88Issue #:Start Page: 156.e11End Page: 156.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.12.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7085451Citation Count: 20
-
OPENTitle: The pattern of fMRI activation with STN DBS reveals symptom-specific networksJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-026-01368-xBest OA location URL: https://www.nature.com/articles/s41531-026-01368-x_reference.pdfCitation Count: 0
-
RESTRICTEDTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 237End Page: 243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3589103Citation Count: 0
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
- The footprint of orthostatic hypotension in parkinsonian syndromes2020RESTRICTEDTitle: The footprint of orthostatic hypotension in parkinsonian syndromesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 107End Page: 109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.029Citation Count: 12
-
OPENTitle: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [ 11 C]Z-3272Journal Name: Canadian Journal of ChemistryPublisher: Canadian Science PublishingVol: 104Issue #: 4Start Page: 349End Page: 355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1139/cjc-2025-0058Best OA location URL: https://doi.org/10.1139/cjc-2025-0058Citation Count: 0
-
OPENTitle: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based MethodJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2095End Page: 2100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28175Citation Count: 33
- A late-onset neurological disorder: is progression inevitable?2022RESTRICTEDTitle: A late-onset neurological disorder: is progression inevitable?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105092End Page: 105092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014Citation Count: 0
- Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremor2018RESTRICTEDTitle: Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremorJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 129Issue #: 10Start Page: 2215End Page: 2216Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2018.07.024Citation Count: 4